Want to see KR:001630 full AI Analyst Report?
Chong Kun Dang Holdings Co., Ltd. (001630) Price & Analysis
001630 Stock Chart & Stats
- Day’s Range
- KRW 35,000.00 - KRW 35,800.00
- 52-Week Range
- KRW 35,000.00 - KRW 55,600.00
- Previous Close
- KRW 35,400.00
- Volume
- N/A
- Average Volume (3M)
- 2,160
- Market Cap
- KRW 169.48B
- Enterprise Value
- KRW 922.22B
- Total Cash (Recent Filing)
- KRW 154.23B
- Total Debt (Recent Filing)
- KRW 602.87B
- Price to Earnings (P/E)
- 2.6
- Beta
- 0.18
- Next Earnings
- Nov 18, 2026
- EPS Estimate
- N/A
- Next Dividend Ex-Date
- N/A
- Dividend Yield
- 3.93%
Bulls Say, Bears Say
Bulls Say
Revenue Rebound
The sharp TTM revenue rebound indicates renewed demand and improved commercial performance across the healthcare portfolio. If sustained, stronger top-line scale can support broader cost absorption, reinforce subsidiary operations, and provide a foundation for more durable earnings growth over the next several quarters.
Healthy Gross Margin
A low-40% gross margin provides meaningful economic value after direct production costs, while the improving net margin shows better bottom-line conversion than in prior periods. This profitability base can support reinvestment in pharmaceutical development and strengthen resilience if revenue growth moderates.
Improving Returns And Operating Cash Flow
Positive operating cash flow and improving return on equity indicate that the group is generating underlying business activity and using its equity base more effectively. These trends can support internal funding and better capital productivity, even though discretionary cash generation remains constrained.
Bears Say
Weak Cash Conversion
Weak conversion of accounting profit into free cash flow reduces the funds available for research, acquisitions, debt reduction, and shareholder distributions. The sharp FCF decline also raises concerns about earnings quality and makes future investment capacity more dependent on operating improvement or external financing.
Inconsistent Operating Profitability
Negative operating margin alongside positive net income suggests that reported earnings are not being consistently generated by core operations. Thin EBITDA further limits operating resilience, leaving profitability vulnerable to cost pressure and making the recent earnings improvement less dependable over the medium term.
Rising Leverage
The increase in debt relative to equity reduces financial flexibility and increases the group’s sensitivity to operating or cash-flow swings. Higher leverage can constrain capital allocation across healthcare subsidiaries and raise the importance of restoring stronger, more reliable cash generation.
001630 FAQ
What was Chong Kun Dang Holdings Co., Ltd.’s price range in the past 12 months?
What is Chong Kun Dang Holdings Co., Ltd.’s market cap?
When is Chong Kun Dang Holdings Co., Ltd.’s upcoming earnings report date?
How were Chong Kun Dang Holdings Co., Ltd.’s earnings last quarter?
Is Chong Kun Dang Holdings Co., Ltd. overvalued?
Does Chong Kun Dang Holdings Co., Ltd. pay dividends?
What is Chong Kun Dang Holdings Co., Ltd.’s EPS estimate?
How many shares outstanding does Chong Kun Dang Holdings Co., Ltd. have?
What happened to Chong Kun Dang Holdings Co., Ltd.’s price movement after its last earnings report?
Which hedge fund is a major shareholder of Chong Kun Dang Holdings Co., Ltd.?
What is the TipRanks Smart Score and how is it calculated?
Company Description
Chong Kun Dang Holdings Co., Ltd.
Based in Seoul, South Korea, Chong Kun Dang Holdings Corp. has manufactured and supplied pharmaceutical goods since its inception in 1941, reaching both South Korean and global markets.
- Sector
- General
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Hee-Nam Choi
- Employees
- 38
- Website
- www.ckd-holdings.com/company/summary.do
- Address
- KR
Chong Kun Dang Holdings Co., Ltd. (001630) Earnings & Revenues
Technical Analysis
Overall Consensus
| Indicator | Bullish | Neutral | Bearish |
|---|---|---|---|
| Overall Consensus | 6 | 4 | 12 |
| Technical Analysis | 4 | 4 | 2 |
| Moving Averages | 2 | 0 | 10 |